Study evaluating intranasal anti-CD3 for treatment of Alzheimer’s disease published in the PNAS journal Sep 10, 2023
MaxCyte signs strategic platform license with prime medicine to advance next-generation gene editing therapies for patients Aug 10, 2023
New study spotlights effective strategy against COVID-19 variants: the E7 monoclonal antibody Aug 1, 2023